1 week Ago By ABMN Staff
Russell Investments Group Ltd. lessened its holdings in shares of Semler Scientific, Inc. ( NASDAQ:SMLR – Free Report ) by 86.
4% during the 4th quarter, HoldingsChannel reports. The fund owned 826 shares of the company’s stock after selling 5,239 shares during the period. Russell Investments Group Ltd.
’s holdings in Semler Scientific were worth $45,000 as of its most recent SEC filing. Other hedge funds have also made changes to their positions in the company. State Street Corp increased its stake in Semler Scientific by 0.
6% in the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after buying an additional 725 shares during the period. Jane Street Group LLC raised its holdings in shares of Semler Scientific by 72.
3% during the third quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock worth $400,000 after acquiring an additional 7,126 shares in the last quarter. Geode Capital Management LLC boosted its position in Semler Scientific by 10.
5% during the third quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock valued at $3,202,000 after purchasing an additional 12,964 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in Semler Scientific in the third quarter valued at about $104,000.
Finally, Principal Financial Group Inc. acquired a new position in Semler Scientific in the 3rd quarter worth about $361,000. 49.
37% of the stock is owned by hedge funds and other institutional investors. Analysts Set New Price Targets Separately, Lake Street Capital boosted their price target on Semler Scientific from $40.00 to $71.
00 and gave the company a “buy” rating in a research note on Friday, January 24th. Semler Scientific Trading Up 7.0 % Semler Scientific stock opened at $36.
84 on Friday. Semler Scientific, Inc. has a 1-year low of $20.
88 and a 1-year high of $81.56. The firm’s fifty day simple moving average is $37.
11 and its 200-day simple moving average is $46.10. The company has a market capitalization of $353.
55 million, a P/E ratio of 7.50 and a beta of 1.29.
Semler Scientific ( NASDAQ:SMLR – Get Free Report ) last posted its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, beating the consensus estimate of $0.
20 by $3.21. The company had revenue of $12.
41 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.
65%. About Semler Scientific ( Free Report ) Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Featured Articles Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. ( NASDAQ:SMLR – Free Report ).
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter ..
